JOSEPHINE REESE: Open Payments
NPI 1962167965 · EAST WAREHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,749 in 99 payments from 8 companies in 2025. Trend: 2023 $1,613 · 2024 $2,497 · 2025 $2,749
Food & beverage: $2,749
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $711 |
| Otsuka America Pharmaceutical, Inc. | 16 | $499 |
| Vanda Pharmaceuticals Inc. | 11 | $414 |
| ABBVIE INC. | 20 | $365 |
| Alkermes, Inc. | 12 | $351 |
| Lundbeck LLC | 9 | $202 |
| Axsome Therapeutics, Inc. | 1 | $104 |
| Neurocrine BioSciences, Inc. | 1 | $102 |
Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, ARISTADA, LYBALVI, Auvelity, INGREZZA.
Industry payments across MA — which companies pay providers there.
